Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS Study.

doi:10.1158/1055-9965.EPI-09-0138

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jul 2009

Evans D Gareth R, Lennard Fiona, Pointon Linda J, Ramus Susan J, Gayther Simon A, Sodha Nayanta, Kwan-Lim Gek E, Leach Martin O, Warren Ruth, Thompson Deborah, Easton Douglas F, Eeles Rosalind

Abstract excerpt

INTRODUCTION: A UK multicenter study compared the performance of contrast enhanced-magnetic resonance imaging with X-Ray Mammography in women at high-risk of breast cancer commencing in 1997. Selection criteria were used to identify women with at least 0.9% annual risk of breast cancer. METHODS: Women at high breast cancer risk, with a strong family history and/or high probability of a BRCA1/BRCA2/TP53 mutation,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Contrast Media

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genes, p53

Share to Mammography

Share to Patient Selection

Share to Population Surveillance

Share to United Kingdom

Source

Open in PubMed Open full text

Identifiers

PMID: 19567506
DOI: 10.1158/1055-9965.EPI-09-0138
PMCID: PMC2869031

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS Study.PMID 19567506Read ↗

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).Semantic proximity Read ↗

Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group.Semantic proximity Read ↗

Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls.Semantic proximity Read ↗

The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk.Semantic proximity Read ↗

Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features.Semantic proximity Read ↗

Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.Semantic proximity Read ↗

The value of clinical breast examination in a breast cancer surveillance program for women with germline BRCA1 or BRCA2 mutations.Semantic proximity Read ↗

The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS).Semantic proximity Read ↗

Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.Semantic proximity Read ↗

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.Semantic proximity Read ↗

Abnormal screens among nonmutation carriers in the High Risk Ontario Breast Screening Program.Semantic proximity Read ↗

Five-year analysis of magnetic resonance imaging as a screening tool in women at hereditary risk of breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.